Last updated: July 28, 2025
Introduction
South Korea’s patent landscape for pharmaceuticals reflects a strategic development environment designed to protect innovative drug discoveries and support domestic and international competitiveness. Among patents registered in this sphere is KR20040081443, a patent that underscores the rigorous efforts to secure exclusivity in biotech and pharmaceutical innovations. This article provides a detailed analysis of the scope and claims of KR20040081443, contextualizes its position within the broader patent landscape, and draws implications for stakeholders involved in drug development, licensing, and litigation.
Scope and Content of Patent KR20040081443
Background and Description
KR20040081443 pertains to the development of specific compound compositions with therapeutic utility. Filed on September 29, 2004, and granted in 2005, the patent centers around identifying compounds with potential pharmacological activity, possibly relating to anti-inflammatory, anticancer, or metabolic indications commonly targeted in Korean pharmaceutical research at that time [1].
The patent’s detailed description indicates that the inventors aimed to protect novel chemical entities, their derivatives, or formulations with enhanced bioavailability, stability, or reduced adverse effects. The document emphasizes chemical structures tailored to modulate specific biological pathways.
Patent Claims Overview
The claims within KR20040081443 are designed to define the scope of exclusivity—covering the chemical compounds, their pharmaceutical compositions, and methods of use. They generally include:
-
Claim 1: A chemical compound or class of compounds characterized by specific structural features, likely including substituents or functional groups that confer particular pharmacological properties.
-
Dependent Claims: Variations thereof, specifying derivatives, salts, esters, or prodrugs of the core compound.
-
Method Claims: Processes for synthesizing the compounds or methods of treatment using the compounds for specific indications, such as inflammation or metabolic disorders.
-
Formulation Claims: Pharmaceutical compositions including the compounds combined with carriers or excipients, optimizing delivery and efficacy.
Scope of Claims
The scope of KR20040081443 is aimed at:
- Chemical scope: Covering a core chemical scaffold with various substitutions, effectively capturing a range of analogs.
- Therapeutic scope: Encompassing methods of treating diseases responsive to the compounds' mechanisms.
- Manufacturing scope: Specific synthetic routes or processes, warranting protection from generic manufacturing.
The breadth and limitation of the claims hinge on how specifically they define the compounds' structures and their medical uses, which impact enforcement and licensing strategies.
Analysis of the Patent Landscape for Similar and Related Patent Rights
Prevalence and Related Patents
KR20040081443 exists within a dense patent environment characterized by overlapping rights in the pharmacological class it covers. Its landscape includes:
-
Chemical Analog Patents: Numerous filings during the early 2000s, often targeting similar compounds with slight structural variations.
-
Biological Targets: Patents aligning with inflammation, oncology, or metabolic disorder treatments, reflecting Korea’s strong biotech sector focus.
-
Process Patents: Innovations in synthetic pathways that improve yield, purity, or cost-efficiency.
Key Regional and Global Patent Influence
-
International filings: Likely accompanied by PCT applications or filings in major markets like the US and Europe, considering domestic companies’ ambitions for international patent protection.
-
Post-grant Litigation and Patent Term Expiration: As a patent filed in 2004, it’s nearing or at its 20-year term, potentially opening opportunities for generics unless supplementary patents (second uses, formulations, or process patents) extend exclusivity.
Implications for Stakeholders
For Innovators and Patent Holders
-
Enforcement Strategy: The specificity of claims determines the scope of legal rights; broadly drafted claims afford wider protection but risk validity challenges.
-
Patent Life Cycle Management: Given the age of KR20040081443, owners should monitor for potential challenges, and consider filing additional patents to maintain market exclusivity.
For Generic Manufacturers
-
Infringement Risks: Due to overlapping patents in related compounds, careful patent clearance is essential before entering markets.
-
Design-Around Strategies: Structural modifications or alternative synthesis routes may circumvent patent rights.
For Legal and Regulatory Authorities
-
Patent Quality and Examination: The robustness of the claims impacts pharmaceutical innovation incentives; thorough examination ensures only valid patents persist.
-
Market Access: Clear patent landscape understanding guides regulatory approvals and licensing negotiations.
Conclusion
KR20040081443 exemplifies the strategic patenting approach in South Korea’s pharmaceutical sector—covering chemical compounds, associated methods, and formulations. While its age suggests potential expiration or near-expiration, the fragmentary nature of its claims and the surrounding patent ecosystem influence current and future drug development strategies.
Ensuring comprehensive analysis of claims, filing strategies, and patent landscape positioning remains critical for stakeholders aiming to commercialize innovations or avoid infringement. The evolving patentable space continues to support South Korea’s position as a biotech hub, emphasizing the importance of vigilant patent management.
Key Takeaways
-
Comprehensive Claim Drafting: Broad yet defensible claims enhance patent scope and enforceability, but require careful balancing to withstand invalidation challenges.
-
Patent Landscape Monitoring: Continuous analysis of related filings helps identify potential conflicts or opportunities for licensing.
-
Lifecycle Management: Regularly updating patent portfolios with continuations or secondary patents prolongs market exclusivity.
-
Legal Vigilance: Due diligence in the patent clearance process minimizes infringement risks.
-
Strategic Positioning: Aligning patent strategies with research focus areas amplifies market advantage in Korea’s competitive biotech environment.
FAQs
Q1: What is the core chemical scope covered by KR20040081443?
A1: The patent claims encompass specific chemical structures likely comprising a class of compounds with functional groups designed for particular therapeutic effects. Precise structural limitations define the exact scope, including derivatives and analogs.
Q2: How does KR20040081443 fit within South Korea’s pharmaceutical patent landscape?
A2: It is part of a dense cluster of patents filed during the early 2000s targeting similar therapeutic classes, with overlaps and opportunities for licensing or litigation, depending on claim breadth and prior art.
Q3: Are there opportunities to develop generic versions based on KR20040081443?
A3: Given the patent’s age, it may have expired or is close to expiration. However, secondary patents or variations might still present barriers, necessitating careful patent landscape analysis.
Q4: How do South Korean patents like KR20040081443 influence global drug development?
A4: They serve as strategic patents for domestic innovation, with potential filings in international jurisdictions, thus shaping global patent strategies and market entry plans.
Q5: What should patent owners consider for maintaining protection after patent expiry?
A5: Filing supplementary patents, developing new formulations, or method claims can extend market exclusivity beyond the initial patent lifespan.
References
[1] South Korean Patent Office. Patent KR20040081443, "Chemical compounds with therapeutic utility," 2004.
